Actinium (225Ac) zadavotide guraxetan (AZD2265 [FPI-2265])
1 treatment and condition followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Actinium (225Ac) zadavotide guraxetan (AZD2265 [FPI-2265]) for prostatic neoplasms | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |